Search Results 261-270 of 18830 for prostate cancer
Brain tumor, breast cancer, colon cancer ... Understanding the Resistance to Enzalutamide in Patients with Castrate Resistant Metastatic Prostate Cancer.
Prostate cancer is one of the most common types of cancer in men. Usually prostate cancer grows slowly and initially remains confined to the prostate gland ...
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.
... prostatic fluid (collected following digital prostate massage) for detection of prostate cancer. A Study of Proton Radiation Divided into Fewer Doses for ...
... cancer, prostate cancer, kidney cancer and other urological conditions. Overview. The Department of Urology-Research at Mayo Clinic has a strong legacy of ...
"Surgery is a common treatment for prostate cancer, especially when we can confirm that the tumor is contained to the prostate. Obviously, physically.
This study evaluates the diagnostic performance and safety of [18F]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate cancer after ...
XmAb®20717 Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer · More about research ...
About this study. A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.
... prostate gland, which is also known as benign prostatic hyperplasia (BPH). ... prostate cancer. Make sure you tell all of your doctors that you are using ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.